CHAPTER 4: VACCINES MARKET, BY TECHNOLOGY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Recombinant and Conjugate Vaccines
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Live Attenuated Vaccines
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Inactivated Vaccines
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Toxoid Vaccines
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Others
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: VACCINES MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Pneumococcal Disease
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Influenza
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Human Papilloma Virus
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Meningococcal Disease
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Rotavirus
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
5.7. Varicella
5.7.1. Key market trends, growth factors and opportunities
5.7.2. Market size and forecast, by region
5.7.3. Market share analysis by country
5.8. Measles, Mumps, and Rubella
5.8.1. Key market trends, growth factors and opportunities
5.8.2. Market size and forecast, by region
5.8.3. Market share analysis by country
5.9. Diphtheria, Pertussis, and Tetanus (DTP)
5.9.1. Key market trends, growth factors and opportunities
5.9.2. Market size and forecast, by region
5.9.3. Market share analysis by country
5.10. Polio
5.10.1. Key market trends, growth factors and opportunities
5.10.2. Market size and forecast, by region
5.10.3. Market share analysis by country
5.11. Hepatitis
5.11.1. Key market trends, growth factors and opportunities
5.11.2. Market size and forecast, by region
5.11.3. Market share analysis by country
5.12. Other Indications
5.12.1. Key market trends, growth factors and opportunities
5.12.2. Market size and forecast, by region
5.12.3. Market share analysis by country
CHAPTER 7: VACCINES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Technology Type
7.2.3. Market size and forecast, by Indication
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Technology Type
7.2.5.1.2. Market size and forecast, by Indication
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Technology Type
7.2.5.2.2. Market size and forecast, by Indication
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Technology Type
7.2.5.3.2. Market size and forecast, by Indication
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Technology Type
7.3.3. Market size and forecast, by Indication
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Technology Type
7.3.5.1.2. Market size and forecast, by Indication
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.3.2. Market size and forecast, by Indication
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Technology Type
7.3.5.4.2. Market size and forecast, by Indication
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Technology Type
7.3.5.5.2. Market size and forecast, by Indication
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Technology Type
7.3.5.6.2. Market size and forecast, by Indication
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Technology Type
7.4.3. Market size and forecast, by Indication
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Technology Type
7.4.5.1.2. Market size and forecast, by Indication
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Technology Type
7.4.5.2.2. Market size and forecast, by Indication
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Technology Type
7.4.5.3.2. Market size and forecast, by Indication
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Technology Type
7.4.5.4.2. Market size and forecast, by Indication
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Technology Type
7.4.5.5.2. Market size and forecast, by Indication
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Technology Type
7.4.5.6.2. Market size and forecast, by Indication
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Technology Type
7.5.3. Market size and forecast, by Indication
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Technology Type
7.5.5.1.2. Market size and forecast, by Indication
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Technology Type
7.5.5.2.2. Market size and forecast, by Indication
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Technology Type
7.5.5.3.2. Market size and forecast, by Indication
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Technology Type
7.5.5.4.2. Market size and forecast, by Indication
7.5.5.4.3. Market size and forecast, by End User
List of Tables
Table 01. Global Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 02. Vaccines Market for Recombinant and Conjugate Vaccines, by Region, 2023-2035 ($Million)
Table 03. Vaccines Market for Live Attenuated Vaccines, by Region, 2023-2035 ($Million)
Table 04. Vaccines Market for Inactivated Vaccines, by Region, 2023-2035 ($Million)
Table 05. Vaccines Market for Toxoid Vaccines, by Region, 2023-2035 ($Million)
Table 06. Vaccines Market for Others, by Region, 2023-2035 ($Million)
Table 07. Global Vaccines Market, by Indication, 2023-2035 ($Million)
Table 08. Vaccines Market for Pneumococcal Disease, by Region, 2023-2035 ($Million)
Table 09. Vaccines Market for Influenza, by Region, 2023-2035 ($Million)
Table 10. Vaccines Market for Human Papilloma Virus, by Region, 2023-2035 ($Million)
Table 11. Vaccines Market for Meningococcal Disease, by Region, 2023-2035 ($Million)
Table 12. Vaccines Market for Rotavirus, by Region, 2023-2035 ($Million)
Table 13. Vaccines Market for Varicella, by Region, 2023-2035 ($Million)
Table 14. Vaccines Market for Measles, Mumps, and Rubella, by Region, 2023-2035 ($Million)
Table 15. Vaccines Market for Diphtheria, Pertussis, and Tetanus (Dtp), by Region, 2023-2035 ($Million)
Table 16. Vaccines Market for Polio, by Region, 2023-2035 ($Million)
Table 17. Vaccines Market for Hepatitis, by Region, 2023-2035 ($Million)
Table 18. Vaccines Market for Other Indications, by Region, 2023-2035 ($Million)
Table 19. Global Vaccines Market, by End-user, 2023-2035 ($Million)
Table 20. Vaccines Market for Pediatric, by Region, 2023-2035 ($Million)
Table 21. Vaccines Market for Adults, by Region, 2023-2035 ($Million)
Table 22. Vaccines Market for Travelers, by Region, 2023-2035 ($Million)
Table 23. Vaccines Market, by Region, 2023-2035 ($Million)
Table 24. North America Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 25. North America Vaccines Market, by Indication, 2023-2035 ($Million)
Table 26. North America Vaccines Market, by End-user, 2023-2035 ($Million)
Table 27. North America Vaccines Market, by Country, 2023-2035 ($Million)
Table 28. U.S. Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 29. U.S. Vaccines Market, by Indication, 2023-2035 ($Million)
Table 30. U.S. Vaccines Market, by End-user, 2023-2035 ($Million)
Table 31. Canada Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 32. Canada Vaccines Market, by Indication, 2023-2035 ($Million)
Table 33. Canada Vaccines Market, by End-user, 2023-2035 ($Million)
Table 34. Mexico Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 35. Mexico Vaccines Market, by Indication, 2023-2035 ($Million)
Table 36. Mexico Vaccines Market, by End-user, 2023-2035 ($Million)
Table 37. Europe Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 38. Europe Vaccines Market, by Indication, 2023-2035 ($Million)
Table 39. Europe Vaccines Market, by End-user, 2023-2035 ($Million)
Table 40. Europe Vaccines Market, by Country, 2023-2035 ($Million)
Table 41. Germany Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 42. Germany Vaccines Market, by Indication, 2023-2035 ($Million)
Table 43. Germany Vaccines Market, by End-user, 2023-2035 ($Million)
Table 44. France Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 45. France Vaccines Market, by Indication, 2023-2035 ($Million)
Table 46. France Vaccines Market, by End-user, 2023-2035 ($Million)
Table 47. UK Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 48. UK Vaccines Market, by Indication, 2023-2035 ($Million)
Table 49. UK Vaccines Market, by End-user, 2023-2035 ($Million)
Table 50. Italy Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 51. Italy Vaccines Market, by Indication, 2023-2035 ($Million)
Table 52. Italy Vaccines Market, by End-user, 2023-2035 ($Million)
Table 53. Spain Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 54. Spain Vaccines Market, by Indication, 2023-2035 ($Million)
Table 55. Spain Vaccines Market, by End-user, 2023-2035 ($Million)
Table 56. Rest of Europe Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 57. Rest of Europe Vaccines Market, by Indication, 2023-2035 ($Million)
Table 58. Rest of Europe Vaccines Market, by End-user, 2023-2035 ($Million)
Table 59. Asia-Pacific Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 60. Asia-Pacific Vaccines Market, by Indication, 2023-2035 ($Million)
Table 61. Asia-Pacific Vaccines Market, by End-user, 2023-2035 ($Million)
Table 62. Asia-Pacific Vaccines Market, by Country, 2023-2035 ($Million)
Table 63. Japan Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 64. Japan Vaccines Market, by Indication, 2023-2035 ($Million)
Table 65. Japan Vaccines Market, by End-user, 2023-2035 ($Million)
Table 66. China Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 67. China Vaccines Market, by Indication, 2023-2035 ($Million)
Table 68. China Vaccines Market, by End-user, 2023-2035 ($Million)
Table 69. India Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 70. India Vaccines Market, by Indication, 2023-2035 ($Million)
Table 71. India Vaccines Market, by End-user, 2023-2035 ($Million)
Table 72. Australia Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 73. Australia Vaccines Market, by Indication, 2023-2035 ($Million)
Table 74. Australia Vaccines Market, by End-user, 2023-2035 ($Million)
Table 75. South Korea Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 76. South Korea Vaccines Market, by Indication, 2023-2035 ($Million)
Table 77. South Korea Vaccines Market, by End-user, 2023-2035 ($Million)
Table 78. Rest of Asia-Pacific Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 79. Rest of Asia-Pacific Vaccines Market, by Indication, 2023-2035 ($Million)
Table 80. Rest of Asia-Pacific Vaccines Market, by End-user, 2023-2035 ($Million)
Table 81. LAMEA Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 82. LAMEA Vaccines Market, by Indication, 2023-2035 ($Million)
Table 83. LAMEA Vaccines Market, by End-user, 2023-2035 ($Million)
Table 84. LAMEA Vaccines Market, by Country, 2023-2035 ($Million)
Table 85. Brazil Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 86. Brazil Vaccines Market, by Indication, 2023-2035 ($Million)
Table 87. Brazil Vaccines Market, by End-user, 2023-2035 ($Million)
Table 88. Saudi Arabia Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 89. Saudi Arabia Vaccines Market, by Indication, 2023-2035 ($Million)
Table 90. Saudi Arabia Vaccines Market, by End-user, 2023-2035 ($Million)
Table 91. South Africa Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 92. South Africa Vaccines Market, by Indication, 2023-2035 ($Million)
Table 93. South Africa Vaccines Market, by End-user, 2023-2035 ($Million)
Table 94. Rest of LAMEA Vaccines Market, by Technology Type, 2023-2035 ($Million)
Table 95. Rest of LAMEA Vaccines Market, by Indication, 2023-2035 ($Million)
Table 96. Rest of LAMEA Vaccines Market, by End-user, 2023-2035 ($Million)
Table 97. Csl Limited: Key Executives
Table 98. Csl Limited: Company Snapshot
Table 99. Csl Limited: Product Segments
Table 100. Csl Limited: Service Segments
Table 101. Csl Limited: Product Portfolio
Table 102. Csl Limited: Key Strategies
Table 103. Emergent Bio Solutions Inc.: Key Executives
Table 104. Emergent Bio Solutions Inc.: Company Snapshot
Table 105. Emergent Bio Solutions Inc.: Product Segments
Table 106. Emergent Bio Solutions Inc.: Service Segments
Table 107. Emergent Bio Solutions Inc.: Product Portfolio
Table 108. Emergent Bio Solutions Inc.: Key Strategies
Table 109. GlaxoSmithKline PLC.: Key Executives
Table 110. GlaxoSmithKline PLC.: Company Snapshot
Table 111. GlaxoSmithKline PLC.: Product Segments
Table 112. GlaxoSmithKline PLC.: Service Segments
Table 113. GlaxoSmithKline PLC.: Product Portfolio
Table 114. GlaxoSmithKline PLC.: Key Strategies
Table 115. Merck & Co. Inc.: Key Executives
Table 116. Merck & Co. Inc.: Company Snapshot
Table 117. Merck & Co. Inc.: Product Segments
Table 118. Merck & Co. Inc.: Service Segments
Table 119. Merck & Co. Inc.: Product Portfolio
Table 120. Merck & Co. Inc.: Key Strategies
Table 121. Pfizer: Key Executives
Table 122. Pfizer: Company Snapshot
Table 123. Pfizer: Product Segments
Table 124. Pfizer: Service Segments
Table 125. Pfizer: Product Portfolio
Table 126. Pfizer: Key Strategies
Table 127. Sanofi: Key Executives
Table 128. Sanofi: Company Snapshot
Table 129. Sanofi: Product Segments
Table 130. Sanofi: Service Segments
Table 131. Sanofi: Product Portfolio
Table 132. Sanofi: Key Strategies
Table 133. Serum Institute of India Pvt. Ltd.: Key Executives
Table 134. Serum Institute of India Pvt. Ltd.: Company Snapshot
Table 135. Serum Institute of India Pvt. Ltd.: Product Segments
Table 136. Serum Institute of India Pvt. Ltd.: Service Segments
Table 137. Serum Institute of India Pvt. Ltd.: Product Portfolio
Table 138. Serum Institute of India Pvt. Ltd.: Key Strategies
Table 139. Bavarian Nordic: Key Executives
Table 140. Bavarian Nordic: Company Snapshot
Table 141. Bavarian Nordic: Product Segments
Table 142. Bavarian Nordic: Service Segments
Table 143. Bavarian Nordic: Product Portfolio
Table 144. Bavarian Nordic: Key Strategies
Table 145. Zhi Fei Biological: Key Executives
Table 146. Zhi Fei Biological: Company Snapshot
Table 147. Zhi Fei Biological: Product Segments
Table 148. Zhi Fei Biological: Service Segments
Table 149. Zhi Fei Biological: Product Portfolio
Table 150. Zhi Fei Biological: Key Strategies
Table 151. Bharat Biotech: Key Executives
Table 152. Bharat Biotech: Company Snapshot
Table 153. Bharat Biotech: Product Segments
Table 154. Bharat Biotech: Service Segments
Table 155. Bharat Biotech: Product Portfolio
Table 156. Bharat Biotech: Key Strategies
List of Figures
Figure 01. Vaccines Market, 2023-2035
Figure 02. Segmentation of Vaccines Market,2023-2035
Figure 03. Top Impacting Factors in Vaccines Market
Figure 04. Top Investment Pockets in Vaccines Market (2024-2035)
Figure 05. Bargaining Power of Suppliers
Figure 06. Bargaining Power of Buyers
Figure 07. Threat of Substitution
Figure 08. Threat of Substitution
Figure 09. Competitive Rivalry
Figure 10. Global Vaccines Market:Drivers, Restraints and Opportunities
Figure 11. Vaccines Market, by Technology Type, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Vaccines Market for Recombinant and Conjugate Vaccines, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Vaccines Market for Live Attenuated Vaccines, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Vaccines Market for Inactivated Vaccines, by Country 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Vaccines Market for Toxoid Vaccines, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Vaccines Market for Others, by Country 2023 and 2035(%)
Figure 17. Vaccines Market, by Indication, 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Vaccines Market for Pneumococcal Disease, by Country 2023 and 2035(%)
Figure 19. Comparative Share Analysis of Vaccines Market for Influenza, by Country 2023 and 2035(%)
Figure 20. Comparative Share Analysis of Vaccines Market for Human Papilloma Virus, by Country 2023 and 2035(%)
Figure 21. Comparative Share Analysis of Vaccines Market for Meningococcal Disease, by Country 2023 and 2035(%)
Figure 22. Comparative Share Analysis of Vaccines Market for Rotavirus, by Country 2023 and 2035(%)
Figure 23. Comparative Share Analysis of Vaccines Market for Varicella, by Country 2023 and 2035(%)
Figure 24. Comparative Share Analysis of Vaccines Market for Measles, Mumps, and Rubella, by Country 2023 and 2035(%)
Figure 25. Comparative Share Analysis of Vaccines Market for Diphtheria, Pertussis, and Tetanus (Dtp), by Country 2023 and 2035(%)
Figure 26. Comparative Share Analysis of Vaccines Market for Polio, by Country 2023 and 2035(%)
Figure 27. Comparative Share Analysis of Vaccines Market for Hepatitis, by Country 2023 and 2035(%)
Figure 28. Comparative Share Analysis of Vaccines Market for Other Indications, by Country 2023 and 2035(%)
Figure 29. Vaccines Market, by End-user, 2023 and 2035(%)
Figure 30. Comparative Share Analysis of Vaccines Market for Pediatric, by Country 2023 and 2035(%)
Figure 31. Comparative Share Analysis of Vaccines Market for Adults, by Country 2023 and 2035(%)
Figure 32. Comparative Share Analysis of Vaccines Market for Travelers, by Country 2023 and 2035(%)
Figure 33. Vaccines Market by Region, 2023 and 2035(%)
Figure 34. U.S. Vaccines Market, 2023-2035 ($Million)
Figure 35. Canada Vaccines Market, 2023-2035 ($Million)
Figure 36. Mexico Vaccines Market, 2023-2035 ($Million)
Figure 37. Germany Vaccines Market, 2023-2035 ($Million)
Figure 38. France Vaccines Market, 2023-2035 ($Million)
Figure 39. UK Vaccines Market, 2023-2035 ($Million)
Figure 40. Italy Vaccines Market, 2023-2035 ($Million)
Figure 41. Spain Vaccines Market, 2023-2035 ($Million)
Figure 42. Rest of Europe Vaccines Market, 2023-2035 ($Million)
Figure 43. Japan Vaccines Market, 2023-2035 ($Million)
Figure 44. China Vaccines Market, 2023-2035 ($Million)
Figure 45. India Vaccines Market, 2023-2035 ($Million)
Figure 46. Australia Vaccines Market, 2023-2035 ($Million)
Figure 47. South Korea Vaccines Market, 2023-2035 ($Million)
Figure 48. Rest of Asia-Pacific Vaccines Market, 2023-2035 ($Million)
Figure 49. Brazil Vaccines Market, 2023-2035 ($Million)
Figure 50. Saudi Arabia Vaccines Market, 2023-2035 ($Million)
Figure 51. South Africa Vaccines Market, 2023-2035 ($Million)
Figure 52. Rest of LAMEA Vaccines Market, 2023-2035 ($Million)
Figure 53. Top Winning Strategies, by Year
Figure 54. Top Winning Strategies, by Development
Figure 55. Top Winning Strategies, by Company
Figure 56. Product Mapping of Top 10 Players
Figure 57. Competitive Dashboard
Figure 58. Competitive Heatmap: Vaccines Market
Figure 59. Top Player Positioning, 2023